Range Low Price High Price Comment
30 days $0.435 $0.435 Tuesday, 23rd Jan 2024 BIOC stock ended at $0.435. During the day the stock fluctuated 0% from a day low at $0.435 to a day high of $0.435.
90 days $0.435 $0.435
52 weeks $0.210 $13.43

Historical Biocept prices

Date Open High Low Close Volume
2023-12-14 $0.435 $0.435 $0.435 $0.435 0
2023-12-13 $0.435 $0.435 $0.435 $0.435 0
2023-12-12 $0.435 $0.435 $0.435 $0.435 0
2023-12-11 $0.435 $0.435 $0.435 $0.435 0
2023-12-08 $0.435 $0.435 $0.435 $0.435 0
2023-12-07 $0.435 $0.435 $0.435 $0.435 0
2023-12-06 $0.435 $0.435 $0.435 $0.435 0
2023-12-05 $0.435 $0.435 $0.435 $0.435 0
2023-12-04 $0.435 $0.435 $0.435 $0.435 0
2023-12-01 $0.435 $0.435 $0.435 $0.435 0
2023-11-30 $0.435 $0.435 $0.435 $0.435 0
2023-11-29 $0.435 $0.435 $0.435 $0.435 0
2023-11-28 $0.435 $0.435 $0.435 $0.435 0
2023-11-27 $0.435 $0.435 $0.435 $0.435 0
2023-11-24 $0.435 $0.435 $0.435 $0.435 0
2023-11-22 $0.435 $0.435 $0.435 $0.435 0
2023-11-21 $0.435 $0.435 $0.435 $0.435 0
2023-11-20 $0.435 $0.435 $0.435 $0.435 0
2023-11-17 $0.435 $0.435 $0.435 $0.435 0
2023-11-16 $0.435 $0.435 $0.435 $0.435 0
2023-11-15 $0.435 $0.435 $0.435 $0.435 0
2023-11-14 $0.435 $0.435 $0.435 $0.435 0
2023-11-13 $0.435 $0.435 $0.435 $0.435 0
2023-11-10 $0.435 $0.435 $0.435 $0.435 0
2023-11-09 $0.435 $0.435 $0.435 $0.435 0
Click to get the best stock tips daily for free!

About Biocept

Biocept Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The compa... BIOC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT